» Patents

Navigate the complex landscape of patent pools in the tech industry with this comprehensive guide. Explore the benefits of shared risk, reduced litigation, and standardization while understanding potential drawbacks, such as antitrust concerns and st… Read More

A Texas federal court jury has found that Google violated a developer’s patent rights and ordered the company to pay $338.7 million in damages. As Reuters reported, the jury found that Google’s Chromecast and other devices infringed patents owned… Read More

The Patent Trial and Appeal Board (PTAB) recently ruled that an important VLSI patent was unpatentable. The patent at issue was responsible for $1.5 billion of a $2.2 billion Texas jury verdict VLSI won in 2021 against Intel for patent infringement.… Read More

The Federal Circuit has issued a non-precedential ruling affirming a decision by the Patent Trial and Appeal Board (PTAB) that claims in a Broadcom patent related to video-on-demand technology were unpatentable. The Broadcom patents at issue were cha… Read More

The phrase “patent pending” (sometimes abbreviated “Pat. Pend.”) can be marked on a product or its packaging or marketing material (such as a website) to alert the public that the manufacturer has applied for a patent for the product (or some… Read More

The Federal Circuit has affirmed a decision by the Patent Trial and Appeal Board (PTAB) that the challenged claims of Bot M8 LLC’s gaming patent, U.S. Patent No. 8,078,540, were unpatentable. Sony Interactive Entertainment LLC petitioned for Inter… Read More

The US Department of Justice (DoJ), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), and Federal Trade Commission (FTC) have released a joint statement on fighting bias and discrimination created via the us… Read More

The US Patent and Trademark Office (USPTO) has vacated Salesforce’s reexaminations against Applications in Internet Time (AIT) because Salesforce was a real-party-in-interest (RPI) in RPX’s previous inter partes review (IPR) against the same pate… Read More